Phosphatidate is an intermediate in the biosynthesis of diacylglycerol, triacylglycerol, phosphatidylethanolamine, phosphatidylcholine and CDP-diacylglycerol. In addition, phosphatidate may be subject to degradation by particulate phospholipases. The factors regulating the disposition of phosphatidate have interested numerous investigators. We have studied the reactions of phosphatidate metabolism in several tissues and under various environmental conditions. Phosphatidate phosphohydrolase activity is found primarily in the microsomal and supernatant fractions of liver, adipose tissue and intestine. Presumably the physiologically important substrate for this reaction is the particulate-bound phosphatidate and methods for the preparation of this substrate have been developed (Fallon et al., 1975) . Radioactively labelled phosphatidate bound to microsomal particles is prepared from sn-[1 ,3-14C]glycerol 3-phosphate. A wide range of microsomal phosphatidate concentrations may be prepared by this technique, although the usual microsomal concentration is approx. 5 nmol/mg of microsomal protein. This substrate has been used in most of our studies of phosphatidate phosphohydrolase, CDP-diacylglycerol formation and phospholipase A.
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There are several lines of evidence which support an important role for phosphatidate phosphohydrolase in the regulation of neutral-lipid formation by liver or adipose-tissue particulate preparations.
(1) The reaction rate of phosphatidate phosphohydrolase under optimum conditions in vitro is the lowest in the overall synthetic pathway in liver microsomal fractions (Lamb & Fallon, 1974a) . The rate of phosphohydrolase activity was determined as 0.6-0.8 nmol/min per mg of microsomal protein when radiolabelled particulate-bound phosphatidate was used as substrate. The overall rate of glycerolipid formation by these microsomal preparations was approx. l.Onmol/min per mg of microsomal protein. The optimum rate of microsomal sn-glycerol 3-phosphate acyltransferase was 5-7-fold higher.
In the presence of added rat liver supernatant fraction the rate of microsomal phosphatidate phosphohydrolase is increased 5-20-fold. However, at ratios of microsomal protein to supernatant protein estimated for the intact cell, the increase in phosphohydrolase activity is much more modest.
(2) Induction of increased liver triacylglycerol formation by administration of a high-fructose diet is accompanied by an equivalent rise in the activity of the phosphohydrolase, as shown in Table 1 . These changes in lipid metabolism occur simultaneously over a 10-day period (Lamb & Fallon, 19746) . Further, the phosphatidate content of liver microsomal preparation is diminished by approx. 15 %, and diacylglycerol increased by approx. 90 % under these dietary conditions.
(3) The increase in liver triacylglycerol content after partial hepatectomy is accompanied by a corresponding increase in phosphatidate phosphohydrolase activity (Mangiapane et al., 1973) .
(4) Several drugs which cause substantial inhibition of phosphatidate phosphohydrolase activity in vitro also result in inhibition of neutral-lipid formation when administered to the intact animal (Brindley & Bowley, 1975; Lamb et al., 1977) . A series of 1,3-bis(substituted phenoxy)-2-propanones inhibited microsomal phosphatidate phosphohydrolase activity as measured in vitro. The inhibition ranged from 8 to 92% total activity.
In animals fed on these agents in laboratory chow the incorporation of [14C]glycerol into hepatic triacylglycerol was decreased by 3-75 %. Agents which caused a 50 % or greater decrease in phosphatidate phosphohydrolase activity in vitro also lowered VOl. 5 hepatic triacylglycerol formation, measured in vivo, by more than 60 %. Although each of these drugs caused some inhibition of sn-glycerol 3-phosphate acyltransferase activity, the correlation between enzyme inhibition and decreased hepatic triacylglycerol formation was better for phosphatidate phosphohydrolase.
(5) Studies of sn-[1 ,3-14C]glycerol 3-phosphate incorporation into glycerolipids by liver microsomal preparations or homogenates have shown rapid accumulation of radioactivity in phosphatidate and a much slower rise in neutral-lipid radioactivity (Lamb & Fallon, 1974a,b; Fallon et al., 1975) .
(6) In the obese rodent an increased capacity for triacylglycerol biosynthesis in both adipose tissue and liver is accompanied by a substantial rise in phosphatidate phosphohydrolase activity, as shown in Table 2 . As indicated by the change in the ratio of neutral lipid to phosphatidate formed, the increase in phosphohydrolase activity exceeded the rise in sn-glycerol 3-phosphate esterification.
Despite the impressive evidence supporting a key role for phosphatidate phosphohydrolase in the regulation of glycerolipid formation, conflicting information is reported from studies in the perfused liver, the intact animal and hepatic cells grown in monolayer (Lamb et al., 1976) . The administration of [14C]glycerol to animals or added to intact hepatocyte preparations does not result in an accumulation of radioactivity in liver phosphatidate. The radiolabel appears promptly in triacylglycerol and complex phospholipids, as shown in Table 3 for hepatic monolayer cells. Similar observations in perfused rat liver or intact animals substantiate this finding. The relatively low concentration of phosphatidate (5 nmol/mg of microsomal protein) and high concentration of diacylglycerol (20nmol/mg of microsomal protein) found in rat liver microsomal preparations (Fallon et al., 1975) also is unexplained by the hypothesis that phosphohydrolase controls the disposition of phosphatidate.
Several considerations may explain the discrepancy between the intact-cell findings and those recorded from various particulate preparations. First, accumulation of phosphatidate within microsomal membranes may inhibit the acylation of sn-glycerol 3-phosphate, thus preventing substantial increase in this acidic phospholipid in the membrane or the accumulation of radioactivity in the intact-cell systems. Secondly, active phospholipases might rapidly dispose of excess of phosphatidate not converted into diacylglycerol. This would require that the activity of these phospholipases be inhibited or inactivated in the particulate preparations. The incubation of radiolabelled phosphatidate bound to microsomal particulate preparations at pH8.3 in the presence of CaZ+ and rat liver homogenate has not revealed any substantial conversion of phosphatidate into either lysophosphatidate or glycerol. If phospholipase is active within the intact cell, this finding may explain the observed discrepancy.
Alternatively, the reaction conditions, e.g. substrate or cofactor concentrations, used in vitro may not properly reflect conditions within the cell. In the physiological setting, cofactors, substrates or another reaction in the enzymic pathway may become rate-limiting. However, this explanation would indicate that the close parallel between liver phosphatidate phosphohydrolase activity and the rate of hepatic triacylglycerol formation is coincidental.
Finally, it seems possible that the rate of phosphatidate formation and its disposition by several metabolic pathways is under independent regulation. Evidence accumulated by Lloyd-Davies & Brindley (1975) and Lamb & Fallon (1974~) suggests that snglycerol 3-phosphate acyltransferase is a rate-controlling reaction in phosphatidate formation. The activity of phosphatidate phosphohydrolase correlates closely with the further metabolism of phosphatidate, especially to triacylglycerol, in both liver and adipose tissue. Conditions which increase phosphohydrolase activity are generally associated with acceleration of triacylglycerol formation without concomitant changes in phospholipid biosynthesis. Inhibition of phosphohydrolase decreases triacylglycerol formation and may result in acidic phospholipid accumulation (Michell et al., 1976) . Despite inconsistencies in current data, the evidence supports a conclusion that phosphatidate phosphohydrolase is important in the regulation of triacylglycerol formation in viuo.
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